Scales (SCL) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
29 Apr, 2026Opening remarks and agenda
Welcomed attendees to the 114th annual meeting, held in hybrid format, confirming quorum and outlining agenda and procedures for questions and voting.
Meeting welcomed shareholders both in person and online, highlighting strong group performance and increased shareholdings in joint ventures.
Introduced Directors, management, auditors, and legal advisors present.
Agenda included reviews by the Chair and Managing Director, M&A summary and outlook, ordinary resolutions, and Q&A.
Financial performance review
Achieved record results for FY2025: underlying EBITDA NZD 137.6m (+50%), underlying NPAT attributable NZD 61.8m (+82%), reported NPAT attributable NZD 101m (+200%).
Revenue reached NZD 899.9m, up 54% from NZD 584.6m in 2024; Mr Apple exported 3.7m TCEs (+21%).
Dividends per share paid increased to 15.0 cents from 8.5 cents in 2024.
Net debt at year-end was NZD 84.1m, reflecting significant investments in joint ventures.
All divisions—Horticulture, Global Proteins, Logistics—delivered strong or record results.
Board and executive committee updates
Alan Isaac retired after 11 years; Paul Munro joined as Director and Audit & Risk Committee Chair.
Steve Kennelly stepped down as CFO, succeeded by Ben Washington in June 2026; Kennelly to become Company Secretary.
Geoff Smith and Charles Ferguson appointed as divisional CEOs for Horticulture/Logistics and Global Proteins, respectively.
Emma Crutchley joined as Future Director.
Latest events from Scales
- Record revenue and profit growth in FY25, with strong outlook for FY26 amid ongoing investments.SCL
H2 202524 Feb 2026 - Record profit, strong dividends, and strategic expansion defined the year.SCL
AGM 20253 Feb 2026 - Net profit rose to $38.1m on strong segment growth and major acquisitions in H1 2024.SCL
H1 202423 Jan 2026 - Strong profit, strategic acquisitions, and climate focus mark a resilient year.SCL
AGM 202419 Jan 2026 - Record profit and EBITDA growth, strong segment results, and positive FY2025 outlook.SCL
H2 202423 Dec 2025 - Net profit up 51% to $57.6m on 17% higher revenue, with upgraded guidance and key investments.SCL
H1 202523 Nov 2025